Que Oncology   Report issue

For profit Phase 2
Founded: Melbourne Australia (2013)
Status: Defunct (2022)

Organization Overview

First Clinical Trial
2014
NCT04080297
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Que Oncology

Active Ingredients

Drugs in Phase 2 Trials (1)

msx-122 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1